PALAZZO, LUCA
PALAZZO, LUCA
Istituto di Endocrinologia e Oncologia Sperimentale ''G. Salvatore'' - IEOS
Exploitation of DarT/DarG biology for a rational design of antimicrobial agents
2023 Catara, Giuliana; Caggiano, Rocco; Palazzo, Luca
The DarT/DarG Toxin-Antitoxin ADP-Ribosylation System as a Novel Target for a Rational Design of Innovative Antimicrobial Strategies
2023 Catara, Giuliana; Caggiano, Rocco; Palazzo, Luca
The disruption of the CCDC6 - PP4 axis induces a BRCAness like phenotype and sensitivity to PARP inhibitors in high-grade serous ovarian carcinoma
2022 Morra, Francesco; Merolla, Francesco; Damia, Giovanna; Ricci, Francesca; Varricchio, Silvia; Ilardi, Gennaro; Arenare, Laura; Califano, Daniela; Napolitano, Virginia; Fruscio, Robert; Melillo, Rosa Marina; Palazzo, Luca; Celetti, Angela
Mono(ADP-ribosyl)ation enzymes and NAD+ metabolism. A Focus on Diseases and Therapeutic Perspectives
2021 Poltronieri, P; Celetti, A; Palazzo, L
(ADP-ribosyl)hydrolases: structure, function, and biology
2020 Rack, Johannes Gregor Matthias; Palazzo, Luca; Ahel, Ivan
Progress and outlook in studying the substrate specificities of PARPs and related enzymes
2020 Suskiewicz Marcin, J; Palazzo, Luca; Hughes, Rebecca; Ahel, Ivan
ADP-ribosylation signalling and human disease
2019 Palazzo, Luca; Mikolcevic, Petra; Mikoc, Andreja; Ahel, Ivan
CAF-1 subunits levels suggest combined treatments with PARP-inhibitors and ionizing radiation in advanced HNSCC
2019 Morra F.; Merolla F.; Picardi I.; Russo D.; Ilardi G.; Varricchio S.; Liotti F.; Pacelli R.; Palazzo L.; Mascolo M.; Celetti A.; Staibano S.
PARPs and PAR as novel pharmacological targets for the treatment of stress granule-associated disorders
2019 Grimaldi, Giovanna; Catara, Giuliana; Palazzo, Luca; Corteggio, Annunziata; Valente, Carmen; Corda, Daniela
PARPs and PAR as novel pharmacological targets for the treatment of stress granule-associated disorders
2019 Grimaldi, Giovanna; Catara, Giuliana; Palazzo, Luca; Corteggio, Annunziata; Valente, Carmen; Corda, Daniela
Targeting ADP-ribosylation as an antimicrobial strategy
2019 Catara, Giuliana; Corteggio, Annunziata; Valente, Carmen; Grimaldi, Giovanna; Palazzo, Luca
MacroD1 Is a Promiscuous ADP-Ribosyl Hydrolase Localized to Mitochondria
2018 Agnew, Thomas; Munnur, Deeksha; Crawford, Kerryanne; Palazzo, Luca; Mikoc, Andreja; Ahel, Ivan
PARPs in genome stability and signal transduction: implications for cancer therapy
2018 Palazzo, Luca; Ahel, Ivan
Serine is the major residue for ADP-ribosylation upon DNA damage
2018 Palazzo, Luca; Leidecker, Orsolya; Prokhorova, Evgeniia; Dauben, Helen; Matic, Ivan; Ahel, Ivan
ADP-ribosylation: new facets of an ancient modification
2017 Palazzo, Luca; Mikoc, Andreja; Ahel, Ivan
Serine ADP-ribosylation reversal by the hydrolase ARH3
2017 Fontana, Pietro; Bonfiglio Juan, Jose; Palazzo, Luca; Bartlett, Edward; Matic, Ivan; Ahel, Ivan
Studying Catabolism of Protein ADP-Ribosylation
2017 Palazzo, Luca; James Dominic, I; Waddell Ian, D; Ahel, Ivan
Disruption of Macrodomain Protein SCO6735 Increases Antibiotic Production in Streptomyces coelicolor
2016 Lalic, Jasna; Marjanovic, Melanija Posavec; Palazzo, Luca; Perina, Dragutin; Sabljic, Igor; Zaja, Rokoz; Colby, Thomas; Plese, Bruna; Halasz, Mirna; Jankevicius, Gytis; Bucca, Giselda; Ahel, Marijan; Matic, Ivan; Cetkovic, Helena; Luic, Marija; Mikoc, Andreja; Ahel, Ivan
ENPP1 processes protein ADP-ribosylation in vitro
2016 Palazzo, Luca; Daniels, Casey M.; Nettleship, Joanne E.; Rahman, Nahid; McPherson, Robert Lyle; Ong, ShaoEn; Kato, Kazuki; Nureki, Osamu; Leung, Anthony K. L.; Ahel, Ivan
Serine is a new target residue for endogenous ADP-ribosylation on histones
2016 Leidecker, Orsolya; Bonfiglio, Juan Jose; Colby, Thomas; Zhang, Qi; Atanassov, Ilian; Zaja, Roko; Palazzo, Luca; Stockum, Anna; Ahel, Ivan; Matic, Ivan
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Exploitation of DarT/DarG biology for a rational design of antimicrobial agents | 1-gen-2023 | Catara, Giuliana; Caggiano, Rocco; Palazzo, Luca | |
| The DarT/DarG Toxin-Antitoxin ADP-Ribosylation System as a Novel Target for a Rational Design of Innovative Antimicrobial Strategies | 1-gen-2023 | Catara, Giuliana; Caggiano, Rocco; Palazzo, Luca | |
| The disruption of the CCDC6 - PP4 axis induces a BRCAness like phenotype and sensitivity to PARP inhibitors in high-grade serous ovarian carcinoma | 1-gen-2022 | Morra, Francesco; Merolla, Francesco; Damia, Giovanna; Ricci, Francesca; Varricchio, Silvia; Ilardi, Gennaro; Arenare, Laura; Califano, Daniela; Napolitano, Virginia; Fruscio, Robert; Melillo, Rosa Marina; Palazzo, Luca; Celetti, Angela | |
| Mono(ADP-ribosyl)ation enzymes and NAD+ metabolism. A Focus on Diseases and Therapeutic Perspectives | 1-gen-2021 | Poltronieri, P; Celetti, A; Palazzo, L | |
| (ADP-ribosyl)hydrolases: structure, function, and biology | 1-gen-2020 | Rack, Johannes Gregor Matthias; Palazzo, Luca; Ahel, Ivan | |
| Progress and outlook in studying the substrate specificities of PARPs and related enzymes | 1-gen-2020 | Suskiewicz Marcin, J; Palazzo, Luca; Hughes, Rebecca; Ahel, Ivan | |
| ADP-ribosylation signalling and human disease | 1-gen-2019 | Palazzo, Luca; Mikolcevic, Petra; Mikoc, Andreja; Ahel, Ivan | |
| CAF-1 subunits levels suggest combined treatments with PARP-inhibitors and ionizing radiation in advanced HNSCC | 1-gen-2019 | Morra F.; Merolla F.; Picardi I.; Russo D.; Ilardi G.; Varricchio S.; Liotti F.; Pacelli R.; Palazzo L.; Mascolo M.; Celetti A.; Staibano S. | |
| PARPs and PAR as novel pharmacological targets for the treatment of stress granule-associated disorders | 1-gen-2019 | Grimaldi, Giovanna; Catara, Giuliana; Palazzo, Luca; Corteggio, Annunziata; Valente, Carmen; Corda, Daniela | |
| PARPs and PAR as novel pharmacological targets for the treatment of stress granule-associated disorders | 1-gen-2019 | Grimaldi, Giovanna; Catara, Giuliana; Palazzo, Luca; Corteggio, Annunziata; Valente, Carmen; Corda, Daniela | |
| Targeting ADP-ribosylation as an antimicrobial strategy | 1-gen-2019 | Catara, Giuliana; Corteggio, Annunziata; Valente, Carmen; Grimaldi, Giovanna; Palazzo, Luca | |
| MacroD1 Is a Promiscuous ADP-Ribosyl Hydrolase Localized to Mitochondria | 1-gen-2018 | Agnew, Thomas; Munnur, Deeksha; Crawford, Kerryanne; Palazzo, Luca; Mikoc, Andreja; Ahel, Ivan | |
| PARPs in genome stability and signal transduction: implications for cancer therapy | 1-gen-2018 | Palazzo, Luca; Ahel, Ivan | |
| Serine is the major residue for ADP-ribosylation upon DNA damage | 1-gen-2018 | Palazzo, Luca; Leidecker, Orsolya; Prokhorova, Evgeniia; Dauben, Helen; Matic, Ivan; Ahel, Ivan | |
| ADP-ribosylation: new facets of an ancient modification | 1-gen-2017 | Palazzo, Luca; Mikoc, Andreja; Ahel, Ivan | |
| Serine ADP-ribosylation reversal by the hydrolase ARH3 | 1-gen-2017 | Fontana, Pietro; Bonfiglio Juan, Jose; Palazzo, Luca; Bartlett, Edward; Matic, Ivan; Ahel, Ivan | |
| Studying Catabolism of Protein ADP-Ribosylation | 1-gen-2017 | Palazzo, Luca; James Dominic, I; Waddell Ian, D; Ahel, Ivan | |
| Disruption of Macrodomain Protein SCO6735 Increases Antibiotic Production in Streptomyces coelicolor | 1-gen-2016 | Lalic, Jasna; Marjanovic, Melanija Posavec; Palazzo, Luca; Perina, Dragutin; Sabljic, Igor; Zaja, Rokoz; Colby, Thomas; Plese, Bruna; Halasz, Mirna; Jankevicius, Gytis; Bucca, Giselda; Ahel, Marijan; Matic, Ivan; Cetkovic, Helena; Luic, Marija; Mikoc, Andreja; Ahel, Ivan | |
| ENPP1 processes protein ADP-ribosylation in vitro | 1-gen-2016 | Palazzo, Luca; Daniels, Casey M.; Nettleship, Joanne E.; Rahman, Nahid; McPherson, Robert Lyle; Ong, ShaoEn; Kato, Kazuki; Nureki, Osamu; Leung, Anthony K. L.; Ahel, Ivan | |
| Serine is a new target residue for endogenous ADP-ribosylation on histones | 1-gen-2016 | Leidecker, Orsolya; Bonfiglio, Juan Jose; Colby, Thomas; Zhang, Qi; Atanassov, Ilian; Zaja, Roko; Palazzo, Luca; Stockum, Anna; Ahel, Ivan; Matic, Ivan |